<DOC>
	<DOCNO>NCT00414570</DOCNO>
	<brief_summary>The objective pilot study ( ) compare response chemotherapy , time disease progression overall survival patient pancreatic cancer treat gemcitabine demonstrate 18F-FLT uptake patient demonstrate 18F-FLT uptake ; ( ii ) correlate 18F-FLT uptake hENT1 expression biopsy sample available ; ( iii ) determine presence absence uptake , relative uptake score ( RUS ) tumor background ratio 18F-FLT patient know carcinoma pancreas assess uptake relation time disease progression ; ( iv ) demonstrate safety 18F-FLT manufactured Edmonton PET Centre .</brief_summary>
	<brief_title>An Imaging Pilot Study 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine ( 18F-FLT ) Patients With Locally Advanced Metastatic Pancreatic Cancer Who Will Treated With Gemcitabine</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Alovudine</mesh_term>
	<criteria>male female ≥ 18 year age . If female child bear potential outside window 10 day since first day last menstrual period , negative pregnancy test patient know locally advanced metastatic carcinoma pancreas plan gemcitabine treatment calculate creatinine clearance &gt; 50ml/min ( calculate Crockcraft Gault equation ) able willing follow instruction comply protocol provide write consent prior participation study Karnofsky Performance Scale Score 60100 Bilirubin ≥200 umol/L AST ALT ≥5 time upper limit normal Serious medical condition may prevent patient tolerate experimental chemotherapy : congestive heart failure , unstable angina , unstable ventricular arrhythmia , uncontrolled psychiatric condition , serious infection , uncontrolled diabetes uncontrolled brain metastasis . Patients stable brain metastasis treat radiation surgery symptomatic stable dose dexamethasone eligible nursing female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Positron Emission Tomography ( PET )</keyword>
	<keyword>3'-deoxy-3 ' ( 18F ) fluorothymidine ( [ 18F ] FLT )</keyword>
</DOC>